Related Experiment Video
Updated: Jul 3, 2026

Intravenous Microinjections of Zebrafish Larvae to Study Acute Kidney Injury
Published on: August 4, 2010
Fatal injection of ranitidine: a case report
Antonio Oliva1, Sara Partemi, Vincenzo Arena
1Institute of Legal Medicine, Catholic University, School of Medicine, Rome, Italy. antonio.oliva@rm.unicatt.it
Introduction:
Ranitidine hydrochloride (Zantac), a histamine-2-receptor antagonist, is a widely used medication with an excellent safety record. Anaphylactic reaction to ranitidine is an extremely rare event and a related death has never been described in the literature.
Case Presentation:
We present the clinical history, histological and toxicological data of a 51-year-old man with negative anamnesis for allergic events, who died suddenly after the intravenous administration of one phial of Zantac 50 mg prescribed as a routine post-surgical prophylaxis for stress ulcer.
Conclusion:
Although the incidence of anaphylactic reactions related to ranitidine is low, caution needs to be exercised on administration of this drug. In addition, further study is needed to define strategies for the prevention of adverse drug reactions in hospitalized patients.
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Pharmaceutical Poisoning: Treatment Strategies
Acute Kidney Injury I: Introduction

